Shkreli's Former Company KaloBios Files for BankruptcyBy and
Biotech company aims to restructure, salvage leukemia drug
KaloBios saw `imminent threat' after Shkreli's arrest
KaloBios Pharmaceuticals Inc., which Martin Shkreli rescued from liquidation last month, filed for bankruptcy after his arrest knocked the biotechnology company’s brief revival off course.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.